Senior Director of R&D
Dr. Riguo Fang is currently the senior director of the research and development department at EdiGene. He is the leader of EdiGene’s hematopoietic stem cell platform.
Dr. Fang has more than ten years of experience in cell technology development and application. He also has extensive experience in the establishment and maintenance of mammalian stem cells and human pluripotent stem cells. His research has been published in well-known journals, including Cell Stem Cell. Dr. Fang has used small chemical molecules to establish the world’s first non-human primate primitive pluripotent stem cell model, as well as an embryonic stem cell model of highly immunodeficient mice. He is the inventor of six patents related to pluripotent and hematopoietic stem cells.
Dr. Fang holds a doctorate degree from Peking University and a bachelor’s degree from Shanghai Jiao Tong University; During his Ph.D. and post-doctoral studies, he studied under Professor Hongkui Deng, an internationally renowned stem cell expert. Dr. Fang is also an Associate Researcher in the Beijing Municipal Nature Science Research Series. He is a leading talent in Guangzhou.